CCSC

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

Koffee Talk: Copay Accumulator Adjustment Programs

Part I: Copay Accumulator Adjust Programs (CAAPs) Overview

Part II: Employer Perspective on CAAPs

References
Patients & Family Caregivers: Prescription Drug Affordability Challenges During COVID-19
How CVS Health Drives McKesson’s Distribution Financials

Part III: Risks to the Patient

References
Building A Healthier Future For All: The 2020 Janssen U.S. Transparency Report
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence

Part IV: Patient Scenario

Part V: Summary

Part VI: NHF Survey Results

 

Jointly provided by

Jointly provided by

    

  • CCSC is supported by charitable donations from founding supporter Takeda, and additional support from BioMarin, Biotechnology Innovation Organization, Bleeding & Clotting Disorders Institute, CSL Behring, Genentech, Inc., Gulf States Hemophilia and Thrombophilia Center, Louisiana Center for Bleeding and Clotting Disorders, Sanofi, and Spark Therapeutics.

  • Copay Accumulator Adjustment Program (CAAP) Outreach is supported by AbbVie, Inc.

    © 2023 National Hemophilia Foundation. All rights reserved.

 

Footer Menu